Cells 12 , 1207 (2023)
BPC-157 accelerates healing but does not create overnight miracles
PubMed Rosenstock, J., Wysham, C., Fras, J.P., Kaneko, S., Lee, C.J., Fernndez Land, L., Mao, H., Cui, X., Karanikas, C.A., & Thieu, V.T
You get the GH pulse without the accompanying appetite spike (GHRP-6 notoriously causes hunger) or the cortisol elevation that undermines recovery
Final research-target dose 2.4 mg + 2.4 mg weekly Titration length ~16 weeks Trial duration 68 weeks (REDEFINE 1 / REDEFINE 2) Route Subcutaneous, once weekly Compound Delivery: 2.4 mg / 2.4 mg Maintenance Pre-blended vials simplify weekly administration to a single injection but lock the ratio at 1:1